287922-71-8 Usage
Description
4-Bromo-1-methyl-1H-pyrazole-3-carbonitrile is an organic compound that serves as a pharmaceutical intermediate. It is characterized by its unique molecular structure, which includes a bromo substituent, a methyl group, and a carbonitrile functional group attached to a pyrazole ring. 4-Bromo-1-methyl-1H-pyrazole-3-carbonitrile plays a crucial role in the synthesis of various pharmaceuticals and has potential applications in the development of new drugs.
Uses
Used in Pharmaceutical Industry:
4-Bromo-1-methyl-1H-pyrazole-3-carbonitrile is used as a pharmaceutical intermediate for the synthesis of various drugs. Its unique molecular structure allows it to be a key component in the development of new pharmaceuticals with potential therapeutic applications.
Used in Benzoylthiophene Synthesis:
4-Bromo-1-methyl-1H-pyrazole-3-carbonitrile is used as a precursor in the synthesis of benzoylthiophenes, which are allosteric enhancers (AE) of agonist activity at the A1 adenosine receptor. These benzoylthiophenes have potential applications in the treatment of various diseases and conditions, such as neurodegenerative disorders, by modulating the activity of the A1 adenosine receptor.
Check Digit Verification of cas no
The CAS Registry Mumber 287922-71-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,7,9,2 and 2 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 287922-71:
(8*2)+(7*8)+(6*7)+(5*9)+(4*2)+(3*2)+(2*7)+(1*1)=188
188 % 10 = 8
So 287922-71-8 is a valid CAS Registry Number.
287922-71-8Relevant articles and documents
AZAINDOLE DERIVATIVE AND USE THEREOF AS FGFR AND C-MET INHIBITOR
-
Paragraph 0185, (2021/05/29)
A series of pyrazolopymidine derivatives, and use thereof in the preparation of a medicament for treating disease associated with FGFR and c-Met. The pyrazolopymidine derivative is a compound represented by formula (I), a tautomer, or a pharmaceutically acceptable salt thereof.
PYRROLE AND PYRAZOLE DERIVATIVES AS POTENTIATORS OF GLUTAMATE RECEPTORS
-
Page/Page column 82, (2008/06/13)
The present invention relates to pyrrole and pyrazole compounds of formula (I) and their pharmaceutically acceptable salts, and further relates to their use in treating schizophrenia, cognitive deficits associated with schizophrenia, Alzheimer's disease, dementia of the Alzheimer's type, mild cognitive impairment, or depression. The compounds act as potentiators on glutamate receptors, in particular AMPA and the GluR family.
